The human evidence is small
The FDA review lists five human studies, as recorded in September 2026.
Adding the review's figures puts the number given BPC-157 at roughly 80.
Only two studies compared people given BPC-157 with people given something else. Neither was published as a detailed report of how the study was done and what it found. They appeared only as short meeting summaries.
A comparison group receives something different, or no treatment, so changes can be compared. Ask whether the study behind an offer had one.
Feeling better does not settle the cause
The small knee-pain report described improvement reported by patients, but it had no comparison group.
That design cannot show that BPC-157 caused the improvement.
The tendon-healing studies discussed in FDA's review were animal studies, rather than evidence of healing in people.
Ask what was measured: a change in pain, movement or something else. Then ask how that result supports the exact claim being made to you.
A study listing gives a plan, not a result
A publicly listed study in China was accepting people with injuries to their rear thigh muscles by September 2026. It had no results yet.
A planned US study after shoulder surgery was not yet accepting people and also had no results.
A public study listing records the plan and how far the study has got; it does not show the treatment works.
Ask to see reported findings when someone points to a trial listing. A link to a planned study does not answer what happened.